Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Injectable bone].

Yoichi Yamada1, Kenichiro Hata, Minoru Ueda

  • 1Department of Oral and Maxillofacial Surgery, Nagoya University, Graduate School of Medicine.

Clinical Calcium
|March 19, 2005
PubMed
Summary

Injectable bone regeneration using mesenchymal stem cells (MSCs) and Platelet-Rich Plasma (PRP) shows promising results. This novel approach effectively promotes new bone formation, offering a potential alternative to traditional bone grafting methods.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Personalized exercise therapy during targeted drug therapy tapering in patients with rheumatoid arthritis: a pilot randomized controlled trial.

BMC rheumatology·2026
Same author

Vaginal microbiota composition in pregnant women following cervical conization and radical trachelectomy.

Scientific reports·2026
Same author

Age-dependent reductions in natural moisturizing factor and caspase-14 in paediatric atopic dermatitis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Two-decade trends in prenatal genetic testing in Japan.

Journal of human genetics·2026
Same author

DNA methylation data from Japanese patients with Rubinstein-Taybi syndrome.

Human genome variation·2025
Same author

Correction: Loss-of-function mutation of NSD2 is associated with abnormal placentation accompanied by fetal growth retardation in mice.

PloS one·2025

Area of Science:

  • Tissue engineering
  • Regenerative medicine
  • Biomaterials science

Context:

  • Bone defects pose significant clinical challenges.
  • Current bone grafting methods have limitations.
  • Need for effective and minimally invasive bone regeneration strategies.

Purpose:

  • To develop an injectable bone substitute using mesenchymal stem cells (MSCs) and Platelet-Rich Plasma (PRP).
  • To evaluate the osteogenic potential and bone regeneration capacity of this injectable composite.
  • To compare the efficacy with traditional bone graft materials.

Summary:

  • Mesenchymal stem cells (MSCs) from bone marrow were combined with beta-tricalcium phosphate (beta-TCP) scaffold and fibrin glue, with or without Platelet-Rich Plasma (PRP).
  • The injectable bone composite was implanted subcutaneously in rats and assessed after 8 weeks.
  • Histological analysis revealed significant new bone formation and neovascularization in the MSCs + PRP group, comparable to autogenous bone marrow.

Impact:

  • Demonstrates the potential of MSCs and PRP as an injectable bone substitute.
  • Offers a promising, less invasive alternative for bone regeneration.
  • Highlights the capacity for significant bone formation and vascularization with the developed material.

Related Experiment Videos